Rosa Jurado-Barba

Dr. Rosa Jurado-Barba

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2010 in European Addiction Research
Verified
Journal Article
Closed access
MAM. Aragues
M. Aragues
RJRosa Jurado-Barba
Rosa Jurado-Barba
RQR. Quinto
R. Quinto
GRGabriel Rubio
Gabriel Rubio
Impulsivity can be defined as choosing a smaller, immediate reward over a larger, delayed reward. From this perspective, addictive behaviors such as substance abuse and pathological gambling reflect a series of impulsive choices. However, impulsivity is not a homogeneous construct. Laboratory measures of impulsivity reflect two types of processes. The first is related to behavioral inhibition and refers to an individual’s ability to appropriately inhibit thoughts or actions. The second is the delay of reward dimension, namely the degree to which immediate (rewarding) consequences have more control over an individual’s behavior than consequences that are delayed. In this review, we describe how alcohol is associated with significant impairments in these paradigms. We also suggest that they may have a role in the development of alcohol dependence. These results are in agreement with a model in which delay of gratification might be a marker for early use and/or abuse of alcohol, whereas impairment in behavioral inhibition might be a marker for maintained use in time and, therefore, for progression towards alcohol dependence.

1 May 2014 in Psicothema
Verified
Journal Article
Closed access
GRGabriel Rubio
Gabriel Rubio
JMJose Martinez-Raga
Jose Martinez-Raga
IMIsabel Martínez-Gras
Isabel Martínez-Gras
GAGuillermo Ponce Alfaro
Guillermo Ponce Alfaro
JBJavier de la Cruz Bértolo
Javier de la Cruz Bértolo
JMJosé Zarco Montejo
José Zarco Montejo
To evaluate the psychometric properties of the Spanish version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and its effectiveness as a screening tool for problematic alcohol, tobacco and other psychoactive substance use in groups of low, moderate, and high risk users. A test battery including the ASSIST and several standardized screening, assessment, and diagnostic instruments was administered to 485 patients recruited in different primary health-care facilities and specialized addiction treatment units from Health Area 11 in Madrid. ASSIST cut-off scores show a good sensitivity and specificity for discrimination between substance use and abuse and between abuse and dependence. Concurrent validity was demonstrated by significant correlations between ASSIST scores and scores from the Mini-International Neuropsychiatric Interview (MINI-Plus), the Alcohol Use Disorders Identification Test (AUDIT), the Revised Fagerstrom Tolerance Questionnaire (RTQ) and the Severity of Dependence Scale (SDS). Psychometric properties of the Spanish version of the ASSIST indicate that is a valid screening test for identifying substance use disorders in various health-care settings.

17 July 2020 in Frontiers in Psychiatry
Verified
Journal Article
Open access
RJRosa Jurado-Barba
Rosa Jurado-Barba
ASAna Sion
Ana Sion
AMAndrés Martínez-Maldonado
Andrés Martínez-Maldonado
IDIsabel Domínguez-Centeno
Isabel Domínguez-Centeno
JPJulio Prieto-Montalvo
Julio Prieto-Montalvo
GRGabriel Rubio
Gabriel Rubio
Addiction management is complex, and it requires a bio-psycho-social perspective, that ought to consider the multiple etiological and developmental factors. Because of this, a large amount of resources has been allocated to assess the vulnerability to dependence, i.e., to identify the processes underlying the transition from substance use to dependence, as well as its course, in order to determine the key points in its prevention, treatment, and recovery. Consequently, knowledge from neuroscience must be taken into account, which is why different initiatives have emerged with this objective, such as the "Research Domain Criteria" (RDoC), and the "Addiction Neuroclinical Assessment" (ANA). Particularly, neuropsychophysiological measures could be used as markers of cognitive and behavioral attributes or traits in alcohol dependence, and even trace clinical change. In this way, the aim of this narrative review is to provide an overview following ANA clinical framework, to the most robust findings in neuropsychophysiological changes in alcohol dependence, that underlie the main cognitive domains implicated in addiction: incentive salience, negative emotionality and executive functioning. The most consistent results have been found in event-related potential (ERP) analysis, especially in the P3 component, that could show a wide clinical utility, mainly for the executive functions. The review also shows the usefulness of other components, implicated in affective and substance-related processing (P1, N1, or the late positive potential LPP), as well as event-related oscillations, such as theta power, with a possible use as vulnerability or clinical marker in alcohol dependence. Finally, new tools emerging from psychophysiology research, based on functional connectivity or brain graph analysis could help towards a better understanding of altered circuits in alcohol dependence, as well as communication efficiency and effort during mental operations. This review concludes with an examination of these tools as possible markers in the clinical field and discusses methodological differences, the need for more replicability studies and incipient lines of work. It also uses consistent findings in psychophysiology to draw possible treatment targets and cognitive profiles in alcohol dependence.

1 January 2016 in Child Abuse & Neglect
Verified
Journal Article
Closed access
MÁMaría José Álvarez-Alonso
María José Álvarez-Alonso
RJRosa Jurado-Barba
Rosa Jurado-Barba
NMN. Martinez-Martin
N. Martinez-Martin
JEJ.C. Espin-Jaime
J.C. Espin-Jaime
CBC. Bolaños-Porrero
C. Bolaños-Porrero
GRGabriel Rubio
Gabriel Rubio

1 November 2012 in Comprehensive Psychiatry
Verified
Journal Article
Closed access
GRGabriel Rubio
Gabriel Rubio
JMJesús Marín-Lozano
Jesús Marín-Lozano
FFFrancisco Ferre
Francisco Ferre
IMIsabel Martínez-Gras
Isabel Martínez-Gras
Roberto Rodriguez-JimenezRoberto Rodriguez-Jimenez
Roberto Rodriguez-Jimenez
TPTomás Palomo
Tomás Palomo

1 December 2016 in Journal of Nervous & Mental Disease
Verified
Journal Article
Closed access
Isabel Morales-MuñozIsabel Morales-Muñoz
Isabel Morales-Muñoz
RJRosa Jurado-Barba
Rosa Jurado-Barba
SFSara Fernández-Guinea
Sara Fernández-Guinea
RRRoberto Rodríguez-Jiménez
Roberto Rodríguez-Jiménez
MJMiguel Ángel Jiménez-Arriero
Miguel Ángel Jiménez-Arriero
GRGabriel Rubio
Gabriel Rubio
Sensory gating deficits are commonly found in patients with schizophrenia. However, there is still scarce research on this issue. Thirty-eight patients with first-episode psychosis (FEP) were compared to thirty-eight controls. A condition-test paradigm of event-related potentials (ERP), prepulse inhibition (PPI), and some specific tasks of the MATRICS Consensus Cognitive Battery (MCCB) were used (i.e., TMT, BACS-SC, and Fluency for processing speed and CPT-IP for attention and vigilance). The ERP components measured were P50, N1, and P2. The PPI intervals examined were 30, 60, and 120 msec. Regarding the MCCB, processing speed and attention/vigilance cognitive domains were selected. FEP patients showed significant deficits in N1 and P2 components, at 30 and 60 PPI levels and in all the MCCB subtests selected. We obtained significant relationships in N1 with PPI-60, and with one MCCB subtest for processing speed. In addition, this same subtest showed significant association with P2. Therefore, sensory gating functioning is widely impaired since the very early stages of schizophrenia.